Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$303.6M
+156.9% from 2023
Prescriptions
13K
$23,954.54 per claim
Patients
2,021
1,231 prescribers
Total spending, 2024
$303.6M
$150,210.71 per patient
Medicare prescription drug plans paid $303.6M for Vyndaqel in 2024, for 12,673 prescriptions and refills to 2,021 patients (up 156.9% from 2023). The average cost per claim was $23,954.54.
Florida had the highest Medicare cost for Vyndaqel in 2024: $26.6M for 1,103 claims, followed by California ($25.4M).
Brian M Drachman, cardiology in Philadelphia, PA, had the highest Medicare cost for Vyndaqel in 2024: 182 claims costing $3.9M.
Vyndaqel is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Brian M Drachman Philadelphia, PA | Cardiology | 182 | 20 | $3.9M |
| Janice Pieretti Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 136 | 20 | $3.3M |
| Edward J Miller |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 529 | 4,705 | 604 | $109.3M |
| 2023 | 563 | 4,948 | 660 | $118.2M |
| 2024 | 1,231 | 12,673 | 2,021 | $303.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 135 |
| 14 |
| $3.1M |
| Joshua D Mitchell Saint Louis, MO | Cardiology | 104 | 15 | $2.4M |
| Sarah Cuddy Boston, MA | Cardiology | 109 | 18 | $2.4M |
| Janell G Frantz Rochester, MN | Nurse Practitioner | 104 | 15 | $2.4M |
| Ronald M Witteles Stanford, CA | Cardiology | 95 | 11 | $2.1M |
| Prem Soman Pittsburgh, PA | Cardiology | 90 | 17 | $2.0M |
| Mazen A Hanna Cleveland, OH | Advanced Heart Failure and Transplant Cardiology | 91 | 13 | $2.0M |
| Mirna M Flores Raudez Weston, FL | Nurse Practitioner | 83 | 13 | $1.9M |
| Kaylee M Baker Philadelphia, PA | Nurse Practitioner | 70 | 12 | $1.8M |
| Karthikeyan Ananthasubramaniam Detroit, MI | Cardiology | 85 | Under 11 | $1.8M |
| Julie Rosenthal Phoenix, AZ | Cardiology | 70 | 13 | $1.8M |
| Joban Vaishnav Baltimore, MD | Cardiology | 58 | Under 11 | $1.7M |
| Josef Stehlik Salt Lake City, UT | Cardiology | 83 | Under 11 | $1.7M |
| Omar F Abou Ezzeddine Rochester, MN | Advanced Heart Failure and Transplant Cardiology | 76 | Under 11 | $1.7M |
| Timothy E Raymond Ft Wright, KY | Advanced Heart Failure and Transplant Cardiology | 60 | Under 11 | $1.6M |
| Daniel D Borgeson Rochester, MN | Cardiology | 72 | Under 11 | $1.6M |
| Sarah C Paciulli Colonial Heights, VA | Nurse Practitioner | 74 | 12 | $1.5M |
| Amit C Patel Indianapolis, IN | Advanced Heart Failure and Transplant Cardiology | 63 | Under 11 | $1.5M |
| David E Steidley Phoenix, AZ | Advanced Heart Failure and Transplant Cardiology | 70 | 11 | $1.5M |
| Mario R Rodriguez Rivera Greenwood, SC | Cardiology | 51 | Under 11 | $1.5M |
| Kunjan A Bhatt Austin, TX | Cardiology | 43 | Under 11 | $1.4M |
| Hanna K Gaggin Boston, MA | Cardiology | 63 | Under 11 | $1.3M |
| Maureen C Geary New York, NY | Nurse Practitioner | 30 | 12 | $1.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 12,673 | $303.6M |